WISBIOMED LLC

WISBIOMED LLC specializes in the design, development, and integration of advanced medical devices and diagnostic systems, leveraging expertise in biomedical engineering and precision instrumentation. The company’s core capabilities center on the engineering of Class II and Class III medical devices, with a focus on regulatory-compliant hardware-software integration, biocompatible materials selection, and FDA-aligned validation protocols. Their technical proficiency includes embedded medical system design, signal processing for physiological data acquisition, and compliance with ISO 13485 and IEC 60601 standards. WISBIOMED differentiates itself through rapid prototyping of minimally invasive diagnostic platforms and end-to-end development from concept to pre-market submission, emphasizing reliability in high-stakes clinical environments. Award history is not available to determine specific agency engagements or contract patterns, so no definitive agency relationships can be identified. Similarly, without recent award data, no specific programmatic work streams or procurement trends can be confirmed. The company operates under NAICS 334516, which encompasses the manufacturing of electromedical and electrotherapeutic apparatus, indicating a focus on diagnostic and therapeutic medical equipment requiring precision engineering and regulatory oversight. This places WISBIOMED within the medical device innovation sector, serving the growing demand for next-generation point-of-care and wearable diagnostic technologies. WISBIOMED LLC is structured as a small business entity (ZZ classification) headquartered in Foster City, California, with no publicly disclosed government certifications. Its geographic positioning in the San Francisco Bay Area aligns it with the broader biotech and medtech innovation corridor, positioning the firm to collaborate with academic research institutions, venture-backed startups, and federal research partners in the life sciences ecosystem.